IP Verse

Saccharomyces Boulardii For The Treatment Of Mood Disorders - EP3664894

The patent EP3664894 was granted to Biocodex on Sep 29, 2021. The application was originally filed on Aug 10, 2018 under application number EP18762232A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3664894

BIOCODEX
Application Number
EP18762232A
Filing Date
Aug 10, 2018
Status
Granted And Under Opposition
Aug 27, 2021
Grant Date
Sep 29, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LESAFFREJun 24, 2022BANDPAY & GREUTERADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2006140974
OPPOSITIONEP2110028
OPPOSITIONEP2438821
OPPOSITIONEP3072518
OPPOSITIONUS2006140974
OPPOSITIONUS2011027348
OPPOSITIONUS2013190400
OPPOSITIONUS2016206670
OPPOSITIONWO2012001640
OPPOSITIONWO2016065419

Non-Patent Literature (NPL) Citations (25) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BRAUN et al., Pharmacol. Biochem. Behav., (20110000), vol. 97, pages 406 - 415-
DESCRIPTION- DESBONNET et al., Neuroscience, (20100000), vol. 170, pages 1179 - 1188-
DESCRIPTION- HENNEQUIN et al., J. Clin. Microbiol., (20010000), vol. 39, pages 551 - 559-
DESCRIPTION- KOTOWSKA et al., Aliment Pharmacol Ther, (20050000), vol. 21, pages 583 - 590-
DESCRIPTION- KULKARNI et al., Methods Find Exp Clin Pharmacol, (20070000), vol. 29, pages 343 - 348-
DESCRIPTION- PORSOLT et al., Act. Int. Pharmacodyn. Ther., (19770000), vol. 229, pages 327 - 336-
DESCRIPTION- SHEPHERD et al., Psychopharmacology (Berl), (19940000), vol. 116, pages 56 - 64-
DESCRIPTION- SURAWICZ et al., Clin Infect Dis, (20000000), vol. 31, pages 1012 - 1017-
DESCRIPTION- SURAWICZ et al., Gastroenterology, (19890000), vol. 96, pages 981 - 988-
DESCRIPTION- SZAJEWSKA et al., J Aliment Pharmacol Ther, (20070000), vol. 25, pages 257 - 264-
DESCRIPTION- TOOTHAKER; ELMER, Antimicrobial Agents and Chemotherapy, (19840000), vol. 26, pages 552 - 556-
DESCRIPTION- "«Troubles dépressifs» (« Depressive Disorders »)", manuel diagnostique et statistique des troubles mentaux («(Diagnostic and statistical manual of mental disorders», American Psychiatrie Association, (20130000), pages 155 - 188-
DESCRIPTION- VILLARRUEL et al., Acta Paediatr, (20070000), vol. 96, pages 538 - 541-
INTERNATIONAL-SEARCH-REPORT- BUTS JEAN-PAUL, "Twenty-Five Years of Research on Saccharomyces boulardii Trophic Effects: Updates and Perspectives", DIGESTIVE DISEASES AND SCIENCES, (200901), vol. 54, no. 1, pages 15 - 18, XP002778132 [A] 1-20 * the whole document *-
OPPOSITION- Anonymous, "Dysphorie", Wikipedia, (20170715), pages 1 - 2, Wikipedia, (20230811), XP093073040-
OPPOSITION- Ash Michael E, "A Novel Approach to Treating Depression", FOCUS ALLERGY RESEARCH GROUP newsletter, (20090901), XP055945469-
OPPOSITION- Choi Chang Hwan, Et Al, "A Randomized, Double-blind, Placebo-controlled Multicenter Trial of Saccharomyces boulardii in Irritable Bowel Syndrome, Effect on Quality of Life", Clin. Gastroenterol., (20110901), vol. 45, no. 8, pages 679 - 683, XP055945487-
OPPOSITION- LUIS BUSTOS FERNÁNDEZ et al., "Human gut microbiota - A lifetime history: from birth to adulthood", Acta Gastroenterol. Latinoam., (20160000), vol. 46, pages 375 - 382, XP055945356-
OPPOSITION- Parker George F, "DSM-5 and Psychotic and Mood Disorders", J Am Acad Psychiatry Law, (20140101), vol. 42, pages 182 - 190, XP055945349-
OPPOSITION- Umbrello Giulia, Et Al, "Microbiota and neurologic diseases: potential effects of probiotics", Journal of Translational Medicine, (20160101), vol. 14, no. 298, pages 1 - 11, XP055945352-
OPPOSITION- Watawana M I, Et Al, "Health, Wellness, and Safety Aspects of the Consumption of Kombucha", Journal of Chemistry, (20150101), pages 1 - 11, XP055945464-
OPPOSITION- YONG LU et al., "Therapeutic effects of flupentixol and melitracen combined with Saccharomyces boulardii in patients with diarrhea-predominant irritable bowel syndrome", World Chinese J. of Digestology, (20170000), vol. 25, no. 11, pages 1031 - 1036, XP055945481-
OPPOSITION- PAUL FORSYTHE et al., "Mood and gut feelings", Brain, Behavior, and Immunity, (20100000), vol. 24, pages 9 - 16, XP026783681
OPPOSITION- TIMOTHY DINAN, "How the gut influences the brain: the intestinal microbiome as a new dimension for understanding mental health", European Neuropsychopharmacology, (20160000), vol. 26, pages S23 - S24, XP029434878
OPPOSITION- VALENTINA FABIANO et al., "Probiotics: current evidences and new perspectives", Italian Journal of Pediatrics, (20140000), vol. 40, doi:10.1186/1824-7288-40-S1-A46, page A46, XP021192361

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents